Table 2.
Number of sites and number of spectra per site obtained in each sample.
| Individual | Biopsies | Type | Raman Spectroscopy Acquisition |
|---|---|---|---|
| #1 | 1 | Benign mixed tumor | Mineralized area—10 sites, 3 spectra each |
| Demineralized area—9 sites, 3 spectra each | |||
| Secretions inside ectasia duct—6 sites, 3 spectra each | |||
| #2 | 1 | Benign mixed tumor | Calcification type II—12 sites, 3 spectra each |
| Parenchyma—9 sites, 3 spectra each | |||
| 2 | Non-neoplastic glandular tissue | Strong background fluorescence throughout the sample | |
| #3 | 1 | Mixed carcinoma | Mineralized are—11 sites, 3 spectra each |
| Parenchyma—15 sites, 3 spectra each | |||
| #4 | 1 | Carcinosarcoma | 15 sites, 3 spectra each |
| #5 | 1 | Comedocarcinoma | Strong background fluorescence throughout the sample |
| #6 | 1 | Non-neoplastic glandular tissue | Strong background fluorescence throughout the sample |